A break through solution
for repackaged
Bevacizumab (Avastin®)*
The MEDIVANT® Advantage
USP Type 1 Glass Syringe
Ompi Alba Biologic Glass Syringes. Designed for precision, safety, and enhanced user experience.
Longer Beyond-Use Date (BUD)
Provides greater flexibility and reduced waste for healthcare facilities. (12–months)
High-Grade Automation
Ensures superior product quality and consistency across every batch.
Reliable Supply Chain
Seamless ordering process and commitment to dependable product availability, support and fulfilment.
cGMP Lab Testing on Every Batch
Ensures quality with Pharma-Grade Automation.
Disclaimer: “Avastin® is a registered trademark of Genentech, Inc. Medivant Healthcare is not affiliated with, endorsed by, or sponsored by Genentech, Inc. The use of the name Avastin® in this material is for identification and reference purposes only and does not imply any association with the trademark holder.”